Capecitabine News and Research

RSS
Bristol-Myers Squibb granted NDA for ixabepilone

Bristol-Myers Squibb granted NDA for ixabepilone

ADVENTRX announces positive data from multidrug therapy with cofactor

ADVENTRX announces positive data from multidrug therapy with cofactor

Trial of new therapy for pancreatic cancer

Trial of new therapy for pancreatic cancer

Tykerb (lapatinib) - new anti-cancer treatment approved

Tykerb (lapatinib) - new anti-cancer treatment approved

New data show Enzastaurin's activity across multiple cancer cell lines

New data show Enzastaurin's activity across multiple cancer cell lines

Capecitabine and Gemcitabine help battle pancreatic cancer

Capecitabine and Gemcitabine help battle pancreatic cancer

New chemo combo means longer life for pancreatic cancer patients

New chemo combo means longer life for pancreatic cancer patients

The CMS demonstration project in oncology

The CMS demonstration project in oncology

FDA approves Xeloda (capecitabine) oral chemotherapy

FDA approves Xeloda (capecitabine) oral chemotherapy

Chemotherapy options improve for patients with advanced colorectal cancer

Chemotherapy options improve for patients with advanced colorectal cancer

New generation drug therapy targets the individual

New generation drug therapy targets the individual